We determined the AGR3 protein level in an age-matched cohort of 40 serum pairs (i.e. 40 serum samples derived from breast cancer patients and 40 sera derived from healthy donors) using a commercially available ELISA kit. This evidence concerns the gene AGR3 and breast carcinoma.